Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hailin Tang

Showing results (101-110 of 341) with videos related to

Pageof 35
Sort By:
Oncogene|July 26, 2018
Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34aXiaojia Huang, Xinhua Xie, Peng Liu, et al.
Journal of Neuro-Oncology|December 14, 2011
F10 gene hypomethylation, a putative biomarker for glioma prognosisXiaoping Liu, Hailin Tang, Zeyou Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2011
Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinomaChen Huang, Hailin Tang, Wenling Zhang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based StudyPing Yu, Hailin Tang, Yutian Zou, et al.
Frontiers in Pharmacology|September 7, 2018
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast CancerPeng Liu, Hailin Tang, Cailu Song, et al.
Cancer Communications (London, England)|May 10, 2019
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?Jin Wang, Hailin Tang, Xing Li, et al.
Journal of Cellular and Molecular Medicine|October 11, 2019
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancerHailin Tang, Cailu Song, Feng Ye, et al.
Molecular and Cellular Biochemistry|January 10, 2014
MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinomaYingnan Sun, Shourong Shen, Xiaoping Liu, et al.
Cell Proliferation|July 15, 2025
Endocrine Resistance Score Based on Three Key Genes Predicts Prognosis and Reveals Potential Therapeutic Targets for ER+HER2- Breast CancerLiqin Ping, Lewei Zhu, Nian Chen, et al.
Oncology Research|December 22, 2025
Unraveling Immunotherapy Resistance in Solid Tumors: Decoding Mechanisms and Charting Future Therapeutic LandscapesHuan Wang, Jindong Xie, Na Li, et al.
Pageof 35

Showing results (101-110 of 341) with videos related to

Sort By:
Pageof 35
Oncogene|July 26, 2018
Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34aXiaojia Huang, Xinhua Xie, Peng Liu, et al.
Journal of Neuro-Oncology|December 14, 2011
F10 gene hypomethylation, a putative biomarker for glioma prognosisXiaoping Liu, Hailin Tang, Zeyou Wang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2011
Integrated analysis of multiple gene expression profiling datasets revealed novel gene signatures and molecular markers in nasopharyngeal carcinomaChen Huang, Hailin Tang, Wenling Zhang, et al.
Cancer Control : Journal of the Moffitt Cancer Center|December 28, 2020
Breast-Conserving Therapy Versus Mastectomy in Young Breast Cancer Patients Concerning Molecular Subtypes: A SEER Population-Based StudyPing Yu, Hailin Tang, Yutian Zou, et al.
Frontiers in Pharmacology|September 7, 2018
SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast CancerPeng Liu, Hailin Tang, Cailu Song, et al.
Cancer Communications (London, England)|May 10, 2019
Is surgical axillary staging necessary in women with T1 breast cancer who are treated with breast-conserving therapy?Jin Wang, Hailin Tang, Xing Li, et al.
Journal of Cellular and Molecular Medicine|October 11, 2019
miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancerHailin Tang, Cailu Song, Feng Ye, et al.
Molecular and Cellular Biochemistry|January 10, 2014
MiR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinomaYingnan Sun, Shourong Shen, Xiaoping Liu, et al.
Cell Proliferation|July 15, 2025
Endocrine Resistance Score Based on Three Key Genes Predicts Prognosis and Reveals Potential Therapeutic Targets for ER+HER2- Breast CancerLiqin Ping, Lewei Zhu, Nian Chen, et al.
Oncology Research|December 22, 2025
Unraveling Immunotherapy Resistance in Solid Tumors: Decoding Mechanisms and Charting Future Therapeutic LandscapesHuan Wang, Jindong Xie, Na Li, et al.
Pageof 35